Browse Guides  internal medicine  cardiology

Acute coronary syndrome

Prevalence
Clinical features
Differential diagnosis
Investigations
Therapy
Prevention
Prognosis
Prevention

Cholesterol

using gemfibrozil for patients with a low HDL levels a

Why?

  • Men with low HDL levels who take gemfibrozil are less likely to have an MI or die from heart disease.  There is no clear effect on stroke a

Gemfibrozil reduces MI and death from heart disease in patients with low HDL levels

Patient Treatment Comparison Outcome CER RRR
(95% CI)
NNT
(95% CI)
MI or angina, and HDL <1.0 mmol/l a gemfibrozil placebo non-fatal MI or death due to heart disease
at 5 years
22% 20%
(6.0% to 32%)
23  (12 to 77)

 

 

Expiry date: June 2003
Levels of Evidence used in grading these guides

Authors   CM   Ball , N   Shenker
Reviewer   I K   Jang
CAT Writers   N   Shenker , CJ   Wotton , CM   Ball , RS   Phillips